This company listing is no longer active
Société ADWYA Valuation
Is ADWYA undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Analyst Forecast
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ADWYA?
Other financial metrics that can be useful for relative valuation.
What is ADWYA's n/a Ratio? | |
---|---|
n/a Ratio | 0x |
n/a | n/a |
Market Cap | د.ت128.09m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 1.7x |
Enterprise Value/EBITDA | 13.7x |
PEG Ratio | 3.8x |
Price to Sales Ratio vs Peers
How does ADWYA's PS Ratio compare to its peers?
Company | PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 1.5x | ||
UMED Unité de Fabrication des Médicaments | 2.2x | 8.0% | د.ت248.0m |
SPL Starpharma Holdings | 13.2x | n/a | AU$53.4m |
541096 Bharat Parenterals | 1.3x | n/a | ₹3.6b |
APPH Apontis Pharma | 0.7x | 15.1% | €32.1m |
ADWYA Société ADWYA | 1.2x | 7.0% | د.ت128.1m |
Price-To-Sales vs Peers: ADWYA is good value based on its Price-To-Sales Ratio (1.2x) compared to the peer average (1.5x).
Price to Earnings Ratio vs Industry
How does ADWYA's PE Ratio compare vs other companies in the African Pharmaceuticals Industry?
Price-To-Sales vs Industry: ADWYA is expensive based on its Price-To-Sales Ratio (1.2x) compared to the African Pharmaceuticals industry average (0.9x)
Price to Sales Ratio vs Fair Ratio
What is ADWYA's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 1.2x |
Fair PS Ratio | 1.5x |
Price-To-Sales vs Fair Ratio: ADWYA is good value based on its Price-To-Sales Ratio (1.2x) compared to the estimated Fair Price-To-Sales Ratio (1.5x).
Share Price vs Fair Value
What is the Fair Price of ADWYA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: ADWYA (TND5.95) is trading above our estimate of fair value (TND0.61)
Significantly Below Fair Value: ADWYA is trading above our estimate of fair value.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.